Metastatic Prostate Tumor Study May Reveal Novel Tailored Treatment Avenues

Metastatic Prostate Tumor Study May Reveal Novel Tailored Treatment Avenues
Researchers at the University of California, Santa Cruz, and the University of California, Los Angeles (UCLA) have identified abnormal signaling pathways in metastatic prostate cancer cells that play a crucial role in tumor cell proliferation and in resistance to androgen-deprivation therapy. Results of the study, “Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer,” published in the

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *